Abstract
Thymic stromal lymphopoietin (TSLP) is an interleukin (IL)-7-like cytokine that has recently been implicated as central to the microenvironment and is permissive for the immunologic cascade that initiates and propagates allergic immune responses. In humans, TSLP is produced predominantly by epithelial cells and activated mast cells, and stimulates myeloid dendritic cells (mDC), which uniquely express the heterodimeric TSLP receptor. TSLP-activated mDC can promote naïve CD4+ T cells to differentiate into a Th2 phenotype and can promote the expansion of CD4+ Th2 memory cells. Recent evidence implicates TSLP as playing a pivotal role in the pathobiology of allergic asthma and atopic dermatitis. The potential for TSLP to provide a new therapeutic target for the treatment of allergic disorders is compelling, and elucidating the mechanisms that regulate TSLP expression and the effects of TSLP on orchestrating the immune response toward a Th2 phenotype should facilitate this quest.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References and Recommended Reading
Liu YJ: Thymic stromal lymphopoietin: master switch for allergic inflammation. J Exp Med 2006, 203:269–273. This article provides an excellent up-to-date review.
Sims JE, Williams DE, Morrissey PJ, et al.: Molecular cloning and biological characterization of a novel murine lymphoid growth factor. J Exp Med 2000, 192:671–680.
Friend SL, Hosier S, Nelson A, et al.: A thymic stromal cell line supports in vitro development of surface IgM+ B cells and produces a novel growth factor affecting B and T lineage cells. Exp Hematol 1994, 22:321–328.
Pandey A, Ozaki K, Baumann H, et al.: Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin. Nat Immunol 2000, 1:59–64.
Park LS, Martin U, Garka K, et al.: Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: formation of a functional heteromeric complex requires interleukin 7 receptor. J Exp Med 2000, 192:659–670.
Fujio K, Nosaka T, Kojima T, et al.: Molecular cloning of a novel type 1 cytokine receptor similar to the common gamma chain. Blood 2000, 95:2204–2210.
Hiroyama T, Iwama A, Morita Y, et al.: Molecular cloning and characterization of CRLM-2, a novel type I cytokine receptor preferentially expressed in hematopoietic cells. Biochem Biophys Res Commun 2000, 272:224–229.
Reche PA, Soumelis V, Gorman DM, et al.: Human thymic stromal lymphopoietin preferentially stimulates myeloid cells. J Immunol 2001, 167:336–343.
Soumelis V, Reche PA, Kanzler H, et al.: Human epithelial cells trigger dendritic cell-mediated allergic inflammation by producing TSLP. Nat Immunol 2002, 3:673–680.
Walley AJ, Wiltshire S, Ellis CM, et al.: Linkage and allelic association of chromosome 5 cytokine cluster genetic markers with atopy and asthma associated traits. Genomics 2001, 72:15–20.
Sutherland GR, Baker E, Fernandez KE, et al.: The gene for human interleukin 7 (IL7) is at 8q12-13. Hum Genet 1989, 82:371–372.
Watanabe N, Wang YH, Lee HK, et al.: Hassall’s corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature 2005, 436:1181–1185. This is the seminal article on the role of TSLP in the thymus.
Soumelis V, Liu YJ: Human thymic stromal lymphopoietin: a novel epithelial cell-derived cytokine and a potential key player in the induction of allergic inflammation. Springer Semin Immunopathol 2004, 25:325–333.
Ito T, Wang YH, Duramad O, et al.: TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J Exp Med 2005, 202:1213–1223. This article clarifies the key role of OX20 ligand in mDC activation of Th2 cells.
Giliani S, Mori L, de Saint Basile G, et al.: Interleukin-7 receptor alpha (IL-7Ralpha) deficiency: cellular and molecular bases. Analysis of clinical, immunological, and molecular features in 16 novel patients. Immunol Rev 2005, 203:110–126.
Murata T, Taguchi J, Puri RK, et al.: Sharing of receptor subunits and signal transduction pathway between the IL-4 and IL-13 receptor system. Int J Hematol 1999, 69:13–20.
Isaksen DE, Baumann H, Trobridge PA, et al.: Requirement for stat5 in thymic stromal lymphopoietin-mediated signal transduction. J Immunol 1999, 163:5971–5977.
Liu Y-J: A unified theory of central tolerance in the thymus. Trends Immunol 2006, 27:215–221.
Zhou B, Comeau MR, Smedt TD, et al.: Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice. Nat Immunol 2005, 6:1047–1053. This article demonstrates the role of TSLP in the pathogenesis of allergic asthma in a murine model.
Al-Shami A, Spolski R, Kelly J, et al.: A role for TSLP in the development of inflammation in an asthma model. J Exp Med 2005, 202:829–839. This article demonstrates the role of TSLP in the pathogenesis of allergic asthma in a murine model.
Yoo J, Omori M, Gyarmati D, et al.: Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin. J Exp Med 2005, 202:541–549. This article demonstrates the role of TSLP in the pathogenesis of atopic dermatitis in a murine model.
Li M, Messaddeq N, Teletin M, et al.: Retinoid X receptor ablation in adult mouse keratinocytes generates an atopic dermatitis triggered by thymic stromal lymphopoietin. Proc Natl Acad Sci U S A 2005, 102:14795–14800. This article demonstrates the role of TSLP in the pathogenesis of atopic dermatitis in a murine model.
Ying S, O’Connor B, Ratoff J, et al.: Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity. J Immunol 2005, 174:8183–8190. This article provides the first association of TSLP expression in the airways of asthmatic patients.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Huston, D.P., Liu, Y.J. Thymic stromal lymphopoietin: A potential therapeutic target for allergy and asthma. Curr Allergy Asthma Rep 6, 372–376 (2006). https://doi.org/10.1007/s11882-996-0006-7
Issue Date:
DOI: https://doi.org/10.1007/s11882-996-0006-7